hit counter

Can Lifestyle Factors Modify Risk of Psychiatric Disorders? (2024 Study)

Psychiatric disorders have increasingly become a significant public health concern, affecting a growing number of people globally. A study in focus utilized MR (Mendelian randomization), a method that leverages genetic data to explore causal relationships, to analyze the impact of 45 lifestyle factors on 13 psychiatric disorders. This extensive research involved GWAS summary statistics from …

Read more

Probiotics & Synbiotics for the Metabolic Side Effects of Psychiatric Medications: Are They Effective? (2024 Review)

Patients with severe mental illnesses (SMI), such as schizophrenia and chronic depression, often face the challenge of managing weight gain and metabolic complications, side effects commonly associated with antipsychotics and antidepressants. These medications are known to induce increased appetite and weight gain, leading to long-term metabolic syndromes. Recent studies have evaluated into the role of …

Read more

Long-Term Buprenorphine Treatment: The Impact of Genetic & Psychiatric Factors (2024 Study)

Opioid Use Disorder (OUD) remains a significant public health crisis, with buprenorphine emerging as a key medication in its treatment. Approved by the FDA, buprenorphine works as a partial opioid agonist, helping reduce opioid use and improve treatment retention rates compared to placebo. Despite its effectiveness, challenges in patient retention and optimal treatment duration persist. …

Read more

Detecting Misdiagnosed Bipolar Disorder via MRI Brain Connectivity Analysis (2024 Study)

Bipolar Disorder (BD) and Major Depressive Disorder (MDD) are two of the most prevalent mood disorders, yet they are often misdiagnosed due to overlapping symptoms. This misdiagnosis can lead to inadequate treatment and worsened patient outcomes. However, recent advances in functional magnetic resonance imaging (fMRI) offer a promising solution to this challenge. By analyzing brain …

Read more

Psychedelics for Depression: Targeting the 5-HT2A Receptor & Beyond (2023 Study)

The quest for effective treatments for Major Depressive Disorder (MDD) has taken a revolutionary turn with the exploration of psychedelic compounds. Recent research has evaluated the potential of substances like psilocybin and lisuride, offering new hope for patients unresponsive to traditional antidepressants. Highlights: Traditional Limitations: Standard antidepressants often fail to provide relief for 30% of …

Read more

Unspecified Anxiety Disorder: Expert Treatment Recommendations in Japan (2023)

Anxiety disorders, a widespread mental health concern, encompass a range of conditions, each with specific characteristics and treatment protocols. However, the realm of “unspecified anxiety disorder” remains a grey area, often challenging healthcare professionals due to its lack of clear-cut guidelines. A recent study aimed to fill this gap by developing a consensus among experts …

Read more

Considering Lactate in Psychiatric Disorders & Drug Development (2023 Review)

Lactate, traditionally viewed as a simple metabolic byproduct, is emerging as a significant player in the realm of psychiatric disorders. Recent research reveals its intricate role as both an energy source and a signaling molecule, potentially influencing a wide array of mental health conditions. Highlights: Shift in Lactate Perception: The review highlights a paradigm shift …

Read more